Whartons Jelly Injection Therapy
Whartons Jelly is a ground breaking non-operative treatment option that relieves pain by naturally promoting long lasting healing of musculoskeletal conditions.
How do Wharton’s Jelly Allografts work?
Umbilical cord tissue is shown to be structurally similar to articular cartilage and other soft tissues throughout the body. There are many components of Whartons Jelly (WJ) that are beneficial for transplantation. The most prominent of these components is the ECM (extracellular matrix), a collagen-based, cross-linked network that adds tensile strength and distributes load, making it an excellent choice for patients with musculoskeletal injuries.
Wharton’s jelly (WJ) allografts consist of human umbilical cord tissue that has been disassociated, suspended in saline, and cryopreserved. Their main function is to replace missing or damaged tissue in the patient, applied directly to the defect, or injured area, in soft tissues. They are applied via syringe and are typically used in ligament, muscle, or cartilage tears.
How is Wharton’s jelly administered?
Wharton’s jelly is administered via syringe, directly to the injured site, or defect. The application is relatively painless and takes mere minutes.
How many applications do I need?
This is determined by your physician depending on your specific case, but typically multiple applications are required to reach the desired clinical outcome.
Is Wharton’s jelly application safe?
Yes! There have been no known graft vs. host interactions nor drug interactions with our product. As always, your physician will determine if this product is safe for you. To date, no adverse events have been reported contributable to Regenative Labs’ products in over 50,000 applications.
Regenerative Products Comparison
Which Conditions benefit most from Whartons Jelly?
Wharton’s jelly allografts are connective tissue supplements designed to replace missing or damaged tissue in the patient. If missing or damaged tissue is identified after imaging, you may be a candidate for Wharton’s jelly application.
How do I know if Wharton’s jelly is right for me?
If you are suffering from joint pain, you may have an underlying structural tissue defect that is the root cause. Instead of treating your symptoms (pain) with steroids or other conventional methods, Wharton’s jelly addresses the root cause by fixing your "tissue issue".
Advantages of Whartons Jelly
This connective tissue contains high amounts of extracellular matrix components including collagen types I, III, and V, elastin, and fibronectin that provide a natural
scaffold to facilitate cellular adhesion1, 2. Wharton’s jelly primarily provides cushioning and structural support to the umbilical cord but also contains a natural source of long- chain hyaluronic acid as well as numerous cytokines and growth factors. Studies have described placental tissues to be “immune privileged” as they rarely evoke an immune response in the body, reducing the risk of adverse reaction.
What is a structural defect?
A defect is defined as missing or damaged tissue in the body. Missing or damaged tissue often compromises the stability and structural integrity of its surrounding area, providing for a wide array of symptoms.
Supplementing a Defect
Regenative Labs Wharton’s jelly allografts are derived from the structural connective tissue found in the umbilical cord. This structural connective tissue provides cushioning and structural support to the vasculature in the umbilical cord. All Regenative Labs Wharton’s jelly allografts are processed to preserve the structural integrity and original relevant characteristics of the connective tissue relating to its utility to supplement missing or damaged tissue in the recipient. If you may be dealing with a structural defect, ask your physician if you could benefit from connective tissue supplementation.
What should I do post-application?
This is up to your physician's discretion, however it is usually a good idea to take it easy for the first 24-48 hours, but beyond that, there is typically little change in daily activities post-application. WJ application takes only minutes & is non-allogeneic, non-
surgical, and minimally invasive. Patients walk in and walk back out the same day.
Our Whartons Jelly is developed by Regenative Labs in FL.
Regenative Lab’s mission is to facilitate predictable patient outcomes by providing the highest quality human tissue allografts available. With the goal of addressing the root cause, rather than masking the pain, Regenerative Labs birth tissue allografts provide a non-addictive, minimally invasive option for patients.
Our Lab: Regenative Labs products are manufactured in state-of-the-art ISO certified cleanrooms. All equipment is calibrated and validated to ensure valid and consistent results are produced.
• Advanced Air Quality Systems
• ISO Class 5 Biological Safety Cabinets
• Ultra-Low -80C Freezer Systems
• Advanced Quality Control Systems
Regenative Labs Wharton’s jelly allografts are regulated under section 361 of the Public Health Service Act (PHS) and 21 CFR Part 1271 and are intended for homologous use only. Regenative Labs processes the Wharton’s jelly to preserve the structural integrity and original relevant characteristics of the tissue as observed in the donor.
Regenative Labs’ products are ethically derived and do not contain any material obtained from an embryo or fetus. These birth tissue allografts are derived from healthy, consenting mothers after full-term, live, planned, Cesarean section (C-section) deliveries.
ABOUT REGENATIVE LABS
Regenative Lab’s mission is to facilitate predictable patient outcomes by providing the highest quality human tissue allografts available. With the goal of addressing the root cause, rather than masking the pain, Regenative Labs birth tissue allografts provide a non-addictive, non-invasive option for patients.
Our first-class, state-of-the-art production facility is located in Pensacola, Florida. We spare no expense when it comes to the technology that we all insist is necessary to produce the quality regenerative products we expect for our partners.
REGENATIVE LABS’ HIGH-QUALITY PROCESSING Regenative Labs birth tissue allografts are derived from healthy, consenting mothers after full-term, live, planned, Cesarean section (C-section) deliveries.. Donors are healthy women who are thoroughly screened for risk factors and clinical evidence of relevant communicable diseases. A careful medical and social history is collected in advance to ensure the donor meets all eligibility requirements.
These non-embryonic tissues undergo extensive medical, social and blood testing prior to processing. Only tissue cleared after this stringent screening regimen are processed and re-tested in accordance with standards established by the American Association of Tissue Banks (AATB) and FDA requirements. Every precaution is taken to eliminate potential risk of infectious diseases through comprehensive testing in accordance with the Clinical Laboratory Improvement Amendments of 1988 (CLIA) and 42 CFR Part 493 and the FDA. Regenative Labs verifies each step of the manufacturing process to ensure the most stringent safety standards are met and maintained, from start to finish.